The Potent Novel CDK4/6 Inhibitor TQB3616 in Hormone Receptor Positive Breast Cancer: Preclinical Characterization with in vitro and Human Tumor Xenograft Models
Wenyu Hu,1,* Lei Wang,1,* JiaLing Luo,1 Jian Zhang,2 Nanlin Li1 1Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, Air Force Military Medical University, Xi’an, Shaanxi, People’s Republic of China; 2The State Key Laboratory of Cancer Biology, Department of Biochemistry and...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2023-12-01
|
| Collection: | Breast Cancer: Targets and Therapy |
| Sujets: | |
| Accès en ligne: | https://www.dovepress.com/the-potent-novel-cdk46-inhibitor-tqb3616-in-hormone-receptor-positive--peer-reviewed-fulltext-article-BCTT |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|